New applications for sublingual immunotherapy in allergy.

@article{Incorvaia2009NewAF,
  title={New applications for sublingual immunotherapy in allergy.},
  author={Cristoforo Incorvaia and Marina Mauro and Tiziana Cappelletti and Chiara Pravettoni and Gualtiero Leo and Gian Galeazzo Riario-Sforza},
  journal={Recent patents on inflammation & allergy drug discovery},
  year={2009},
  volume={3 2},
  pages={113-7}
}
Specific immunotherapy is the only treatment targeting the causes, and not only the symptoms, of allergic diseases. Sublingual immunotherapy (SLIT) was introduced and developed to solve the problem of the adverse reactions, uncommon but possibly severe and rarely fatal, to the traditional subcutaneous immunotherapy (SCIT). The evidence of SLIT efficacy concerns rhinitis and asthma caused by sensitization to pollens and to house dust mites, but there are increasing data suggesting that SLIT… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…